IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


(Investigative Ophthalmology and Visual Science. 2004;45:2420-2430.)
© 2004 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.03-1342

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (21)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bush, R. A.
Right arrow Articles by Sieving, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bush, R. A.
Right arrow Articles by Sieving, P. A.

Encapsulated Cell-Based Intraocular Delivery of Ciliary Neurotrophic Factor in Normal Rabbit: Dose-Dependent Effects on ERG and Retinal Histology

Ronald A. Bush,1,2 Bo Lei,1,3,4 Weng Tao,5 Dorit Raz,2 Chi-Chao Chan,6 Terry A. Cox,6 Maria Santos-Muffley,2 and Paul A. Sieving1,2,6

1From the Department of Ophthalmology and Visual Science, Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan; 5Neurotech USA, Lincoln, Rhode Island; the 2National Institute of Deafness and Communication Disorders and the 6National Eye Institute, National Institutes of Health, Bethesda, Maryland; and the 3Department of Veterinary Medicine and Surgery, College of Veterinary Medicine, and the 4Department of Ophthalmology, School of Medicine, University of Missouri, Columbia, Missouri.

PURPOSE. ERG and histologic changes were investigated in normal rabbits after intravitreal implantation of encapsulated cell technology (ECT) devices releasing ciliary neurotrophic factor (CNTF).

METHODS. Fifteen adult New Zealand White albino rabbits had ECT devices secreting CNTF at 22, 5, or 0 ng/d implanted in the superior temporal quadrant of the left eye. The low dose has been shown to produce substantial rescue of photoreceptors in the rcd1 canine model of retinal degeneration. Right eyes were untreated. Ganzfeld dark- and light-adapted ERGs and clinical observations were performed at 5, 15, and 25 days after implantation. Rod a-waves and rod and cone b-waves and outer nuclear layer (ONL) morphology were evaluated at 25 days.

RESULTS. Clinical examination showed minimal changes in a few CNTF-treated eyes, including vitreous membranes and engorgement of iris vessels at day 25. Retinas appeared normal. CNTF did not significantly affect the rod a- or b-waves, although the b-wave amplitude tended to be larger in CNTF-treated retinas at low flash intensities. The cone b-wave amplitude was significantly reduced in high-dose eyes at some flash intensities. The ONL area in high-dose eyes was significantly greater because of increased thickness than in fellow retinas. ONL cell size was significantly increased, and staining density decreased in CNTF-treated retinas.

CONCLUSIONS. CNTF, given by intravitreal ECT device at doses that protect photoreceptors in a canine model of retinal degeneration (5 ng/d), did not adversely affect either rod or cone ERG function of normal rabbit retina. The cone ERG was more sensitive to suppression being reduced, at low flash intensities, by 22 ng/d. Dose-related changes in the ONL and photoreceptor cell nuclei did not represent a toxic effect, because they were not associated with deficits in the rod ERG over a broad range of intensities.





This article has been cited by other articles:


Home page
IOVSHome page
T. J. McGill, G. T. Prusky, R. M. Douglas, D. Yasumura, M. T. Matthes, G. Nune, K. Donohue-Rolfe, H. Yang, D. Niculescu, W. W. Hauswirth, et al.
Intraocular CNTF Reduces Vision in Normal Rats in a Dose-Dependent Manner
Invest. Ophthalmol. Vis. Sci., December 1, 2007; 48(12): 5756 - 5766.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
K. D. Rhee, A. Ruiz, J. L. Duncan, W. W. Hauswirth, M. M. LaVail, D. Bok, and X.-J. Yang
Molecular and Cellular Alterations Induced by Sustained Expression of Ciliary Neurotrophic Factor in a Mouse Model of Retinitis Pigmentosa
Invest. Ophthalmol. Vis. Sci., March 1, 2007; 48(3): 1389 - 1400.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
R. Wen, Y. Song, S. Kjellstrom, A. Tanikawa, Y. Liu, Y. Li, L. Zhao, R. A. Bush, A. M. Laties, and P. A. Sieving
Regulation of Rod Phototransduction Machinery by Ciliary Neurotrophic Factor
J. Neurosci., December 27, 2006; 26(52): 13523 - 13530.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
S. G. Jacobson, A. V. Cideciyan, A. Sumaroka, T. S. Aleman, S. B. Schwartz, E. A. M. Windsor, A. J. Roman, E. M. Stone, and I. M. MacDonald
Remodeling of the Human Retina in Choroideremia: Rab Escort Protein 1 (REP-1) Mutations.
Invest. Ophthalmol. Vis. Sci., September 1, 2006; 47(9): 4113 - 4120.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. A. Sieving, R. C. Caruso, W. Tao, H. R. Coleman, D. J. S. Thompson, K. R. Fullmer, and R. A. Bush
Ciliary neurotrophic factor (CNTF) for human retinal degeneration: Phase I trial of CNTF delivered by encapsulated cell intraocular implants
PNAS, March 7, 2006; 103(10): 3896 - 3901.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
D. Dierks, B. Lei, K. Zhang, and D. P. Hainsworth
Electroretinographic Effects of an Intravitreal Injection of Triamcinolone in Rabbit Retina
Arch Ophthalmol, November 1, 2005; 123(11): 1563 - 1569.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the Association for Research in Vision and Ophthalmology